HSBC Holdings’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
AC
RA
BH
WCM
HSBC Holdings's ANGO Position: Q2 2026 in Review
HSBC Holdings reduced its AngioDynamics (ANGO) stake by 60% in Q2 2026, selling an estimated $464K and leaving 27,526 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #2436.
HSBC Holdings first reported a position in ANGO in Q3 2013 and has held it in 21 quarters since. The position peaked at $801K in Q4 2025. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- HSBC Holdings held 27,526 shares of AngioDynamics worth $356K as of Q2 2026.
- HSBC Holdings sold 40,729 AngioDynamics shares in Q2 2026, an estimated $464K.
- AngioDynamics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2436 holding.
- HSBC Holdings first reported a position in AngioDynamics in Q3 2013 and has held it in 21 quarters since.
- HSBC Holdings's AngioDynamics position peaked at $801K in Q4 2025.
- 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.